Methylenetetrahydrofolate reductase C677T polymorphism in breast cancer risk

Breast Cancer Res Treat. 2010 Aug;122(3):897-8. doi: 10.1007/s10549-010-0938-4. Epub 2010 May 14.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / genetics*
  • Female
  • Humans
  • Meta-Analysis as Topic
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Polymorphism, Genetic / genetics*
  • Prognosis
  • Risk Factors

Substances

  • Methylenetetrahydrofolate Reductase (NADPH2)